Case File
efta-efta02011815DOJ Data Set 10CorrespondenceEFTA Document EFTA02011815
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta02011815
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
jeevacation
mail.com[[email protected]]: Epstein Jeffrey[[email protected]]
From:
Sent:
e
11:17:58 PM
Subject: Fwd: Metavana, Inc. Supplement #3
Sent from my iPhonc
Begin forwarded message:
From: "Spencer Trask'
Date: November 28, 2012, 6:14:20 PM EST
To:
Subject: Metavana, Inc. Supplement #3
To view this email as a web page, go here.
Dear Jeffrey,
Please find the latest Metavana, Inc. supplement: Supplement Number 3. This is the third
supplement to the Metavana, Inc. PPM, dated May 10, 2012.
Sincerely,
Donald Spongberg
Senior Managing Director
Spencer Trask Ventures. Inc. I Member FINRA & SIPC
www.SpencerTraskVentures.com
This matenal is not intended as an offer or solicitation for the purchase or sale of any financial instrument. M offer can
only be made by the confidential Private Placement Memorandum. Past performance is no guarantee of future results.
There are significant risks associated with the Investments and strategies discussed in these materials that may not be
suitable for all investors. The investments discussed are highly illiquid and may fluctuate in price or value. Investors may
get back less than they invested or lose their entire investment. If you have any doubts you should contact your
investment advisor.
EFTA_R1_00513573
EFTA02011815
This email was sent to:
This email was sent by: Spencer Trask Ventures, Inc., Member FINRA and SIPC
750 Third Avenue, 11th Floor, New York, NV, 10017,
We respect your nght to privacy - view our policy
tfilaitnalulacrintionireferences
I Unsubscfl
EFTA_R1_00513574
EFTA02011816
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.spencertraskventures.comEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.